23 March 2018
News and Views
Links and Services
October's issue of the Alimentary Pharmacology & Therapeutics identifies prognostic factors for real-life long-term efficacy of infliximab in Crohn's disease.
The long-term efficacy of infliximab in patients with Crohn's disease is suboptimal.
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors